NCT05714553 2025-07-18
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
NuCana plc
Phase 1/2 Terminated
NuCana plc
Aminex Therapeutics, Inc.
University of California, San Diego
Capital Medical University
Anza Therapeutics, Inc.